Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, PR China.
Nanjing Geneseeq Technology Inc., Nanjing, PR China.
J Pathol Clin Res. 2021 May;7(3):287-300. doi: 10.1002/cjp2.197. Epub 2021 Jan 5.
We collected 26 cases of bronchiolar adenoma (BA) and its variants, and performed a comprehensive characterization using a combination of morphological, immunohistochemical, and genetic assessments. Of these 26, 13 were classic bilayered cases, including 10 proximal and 3 distal-type BAs. Of note, we also identified 13 cases that lacked a continuous basal cell layer. In five cases, the adenomas were partially classic bilayered, leaving a single layer of columnar or cuboidal epithelial cells in some areas of the lesion (BA with monolayered cell lesions). In the other eight cases, the glandular or papillary structures were entirely composed of monolayered columnar or cuboidal epithelial cells, which were morphologically identical to the luminal epithelial cells of classic BA (monolayered BA-like lesions). Immunohistochemical analysis revealed thyroid transcription factor 1 expression by ciliated columnar epithelial cells, basal cells, and nonciliated columnar and cuboidal epithelial cells. Basal cells also expressed p40 and p63. Twenty-five cases underwent next-generation sequencing using a 422-cancer-gene panel (GeneseeqPrime). Oncogenic driver mutations were detected in 23 cases, including 13 (52%) with EGFR mutations, 4 (16%) with KRAS G12D/V mutations, 3 (12%) with BRAF V600E mutations, 2 (8%) with ERBB2 exon 20 insertions, and 1 (4%) with a RET fusion. EGFR exon 20 insertions were present in 100% of BAs with monolayered cell lesions, 37.5% of monolayered BA-like lesions, and 8% of classic BA (Fisher's exact test, p = 0.002, false discovery rate = 0.014). Collectively, our study revealed a gradual morphological transition between BA and its variants. The genetic composition of BAs with monolayered structures differed significantly from those of classic BAs or lung adenocarcinoma.
我们收集了 26 例细支气管腺瘤(BA)及其变体,并通过形态学、免疫组织化学和遗传评估相结合进行了全面特征描述。在这 26 例中,有 13 例是经典双层病例,包括 10 例近端型和 3 例远端型 BA。值得注意的是,我们还发现了 13 例缺乏连续基底细胞层的病例。在 5 例中,腺瘤部分呈经典双层状,在病变的某些区域仅留下单层柱状或立方状上皮细胞(具有单层细胞病变的 BA)。在其他 8 例中,腺管或乳头状结构完全由单层柱状或立方状上皮细胞组成,这些细胞在形态上与经典 BA 的腔上皮细胞相同(单层状 BA 样病变)。免疫组织化学分析显示,纤毛柱状上皮细胞、基底细胞以及非纤毛柱状和立方状上皮细胞均表达甲状腺转录因子 1。基底细胞还表达 p40 和 p63。25 例采用 422 个癌症基因 panel(GeneseeqPrime)进行下一代测序。在 23 例中检测到致癌驱动基因突变,包括 13 例(52%)存在 EGFR 突变,4 例(16%)存在 KRAS G12D/V 突变,3 例(12%)存在 BRAF V600E 突变,2 例(8%)存在 ERBB2 外显子 20 插入,以及 1 例(4%)存在 RET 融合。具有单层细胞病变的 BA 中 EGFR 外显子 20 插入的存在率为 100%,单层状 BA 样病变为 37.5%,经典 BA 为 8%(Fisher 精确检验,p=0.002,错误发现率=0.014)。总之,我们的研究揭示了 BA 及其变体之间存在逐渐的形态学转变。具有单层结构的 BA 的遗传组成与经典 BA 或肺腺癌显著不同。